Results 231 to 240 of about 85,383 (302)

One-year experience with latanoprostene bunod ophthalmic solution 0.024% in clinical practice: A retrospective observational study. [PDF]

PLoS One
Hsueh CM, Tsai CH, Huang JC, Lee SH, Wang TJ, Guo SP.   +5 more
europepmc   +1 more source

Primary open‐angle glaucoma as a marker of upcoming Alzheimer's disease: A 20‐year Danish National Registry‐Based Study

Acta Ophthalmologica, EarlyView.
Abstract Purpose To investigate whether primary open‐angle glaucoma (POAG) is associated with an increased long‐term risk of developing Alzheimer's disease, given its shared neurodegenerative features. Methods A 20‐year longitudinal, registry‐based matched cohort study was conducted using Danish national health registries from 1998 to 2018. Individuals
Cecilia Kronvold, Signe Sperling, Sören Möller, Jakob Grauslund, Lonny Stokholm   +4 more
wiley   +1 more source

Ocular and Plasma Pharmacokinetics of Enavogliflozin Ophthalmic Solution in Preclinical Species. [PDF]

Pharmaceuticals (Basel)
Jang M, Kang M, Lee E, Shin D.
europepmc   +1 more source

Using continuous visual stimulus tracking for detecting visual function loss due to acquired brain injury

Acta Ophthalmologica, EarlyView.
Abstract Purpose Acquired brain injury (ABI) may cause homonymous visual field (VF) defects. Standard automated perimetry (SAP) is the gold standard for VF assessment, but it can be challenging in ABI. Continuous visual stimulus tracking (SONDA; Standardised Oculomotor and Neurological Disorders Assessment) simplifies the perimetric task to following a
A. C. L. Vrijling, M. J. de Boer, R. J. Renken, J. B. C. Marsman, J. Heutink, F. W. Cornelissen, N. M. Jansonius   +6 more
wiley   +1 more source

A zinc oxide-silver nanocomposite-based SERS nanoplatform for ultrasensitive ofloxacin determination in beef and an ophthalmic solution: effects of ZnO and ZnO content on electron transfer and SERS enhancements. [PDF]

RSC Adv
Nga DTN, Nguyen HA, Hoa NT, Ngoc Huyen N, Xuan Dinh N, Ngoc Bach T, Quang Hoa N, Le AT.   +7 more
europepmc   +1 more source

Mast Cells in Acute COVID‐19 Patients

Allergy, EarlyView.
Ilan Zaffran, Hadas Pahima, Eli Ben‐Chetrit, Amir Jarjoui, Ilaria Puxeddu, Carl Zinner, Joana Vitte, Alexandar Tzankov, Francesca Levi‐Schaffer   +8 more
wiley   +1 more source

Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Patients With Dry Eye Disease Associated With Ocular Graft-Versus-Host Disease. [PDF]

Cureus
Wong CW, Le HL, Gombos DS, Yee RW.
europepmc   +1 more source

Correction: Observational Clinical Investigation Evaluating an Ophthalmic Solution Containing Xanthan Gum and Low Concentration Desonide Phosphate in Dry Eye Disease Treatment. [PDF]

Ophthalmol Ther
Aragona P, Giannaccare G, Dammino E, D'Esposito F, Genovese P, Postorino EI, Civiale C, Mazzone MG, Gagliano C.   +8 more
europepmc   +1 more source

Water-Free Cyclosporine Ophthalmic Solution vs Vehicle for Dry Eye Disease: A Randomized Clinical Trial.

JAMA Ophthalmol
Peng R, Jie Y, Long Q, Gong L, Zhu L, Zhong X, Zhao S, Yan X, Gu H, Wu H, Li G, Zhang K, Krösser S, Xu R, Hong J.   +14 more
europepmc   +1 more source